Salus Scientific Closes Series A Financing to Support Occupational Wellness Platform

August 6, 2026—Salus Scientific Corporation announced the closing of its oversubscribed Series A financing, raising a total of $10.1 million.

The financing round, which closed above its $8.0 million target and ahead of schedule, will help support the company’s commercial scale-up, expand its production and clinical infrastructure, and carry it through its revenue ramp, noted the press release.

According to the company, Salus Scientific is building an occupational wellness platform for healthcare organizations to protect the physicians, technologists, and nurses who perform fluoroscopy-guided procedures. It is a developer of radiation protection garments and clinical workflow solutions for fluoroscopy-guided environments.

The company previously noted that its portfolio of occupational wellness solutions includes GLiFT, PeRM, Salus Shield, and the AeroShield enhanced radiation protection device.

“We are pleased to have closed our Series A above target and ahead of schedule,” commented Salus Scientific’s Chairman and Chief Executive Officer Todd Flohr in the company’s press release. “We are thrilled to welcome partners who understand our value proposition and align with the company's long-term vision. That the round closed oversubscribed is, in our view, a direct endorsement of both our commercial thesis and our execution discipline.”